GCG and Prader-Willi syndrome: Although new drugs such as GLP-1 agonists show potential in controlling weight, appetite, and blood glucose in subjects with PWS, diet, physical activity, and behavioral modifications remain the main strategies to promote good metabolic health in these patients.